Cardiomyopathy:
The Voice of the Patient
Download the white paper to learn what patients’ experiences reveal about diagnosis, disease burden, and therapy access
Why This Matters
Inherited cardiomyopathies affect hundreds of thousands of people—yet most patients face substantial diagnostic challenges, inadequate symptom relief, and disconnection from the genetic testing and clinical trials that could transform their care. This impacts not only patient outcomes, but also how new treatments are developed, studied, and delivered.
This white paper brings together patient-reported insights and peer-reviewed literature to highlight gaps in today’s cardiomyopathy care—and where collaboration can drive meaningful change.
What You’ll Learn
Drawing on insights from a nationwide cardiomyopathy patient cohort and peer-reviewed research, this report explores:
- Diagnostic challenges and genetic testing underutilization
- Disease burden and the need for precision therapies
- Patient interest in and awareness of clinical trials
- Strategic opportunities for organizations across sectors
